Mayinglong Pharmaceutical Group Co Ltd Financial Flexibility Index
Mayinglong Pharmaceutical Group Co Ltd financial flexibility index. Mayinglong Pharmaceutical Group Co Ltd (600993) has a Financial Flexibility Index of 0.17x as of September 2025. Free cash flow of CN¥152.93 Million (operating CF CN¥139.20 Million minus capex CN¥13.73 Million) represents 0% of total liabilities (CN¥909.82 Million). See 600993 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Mayinglong Pharmaceutical Group Co Ltd (2003–2025)
Financial flexibility index of Mayinglong Pharmaceutical Group Co Ltd from 2003 to 2025. Historical Financial Flexibility Index trend for Mayinglong Pharmaceutical Group Co Ltd across 23 annual periods. Check 600993 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Mayinglong Pharmaceutical Group Co Ltd Financial Flexibility Index by Year (2003–2025)
Mayinglong Pharmaceutical Group Co Ltd financial flexibility index by year from 2003 to 2025. Year-by-year free cash flow to debt coverage for Mayinglong Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see how efficiently does Mayinglong Pharmaceutical Group Co Ltd generate cash.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.78x | CN¥719.82 Million | CN¥600.44 Million | CN¥921.49 Million | ▲ +9.2% |
| 2024 | 0.72x | CN¥701.46 Million | CN¥497.61 Million | CN¥980.66 Million | ▼ -19.5% |
| 2023 | 0.89x | CN¥852.43 Million | CN¥604.07 Million | CN¥959.62 Million | ▲ +206.6% |
| 2022 | 0.29x | CN¥416.86 Million | CN¥341.85 Million | CN¥1.44 Billion | ▼ -64.4% |
| 2021 | 0.81x | CN¥662.27 Million | CN¥597.17 Million | CN¥812.72 Million | ▲ +128.3% |
| 2020 | 0.36x | CN¥328.40 Million | CN¥282.99 Million | CN¥919.89 Million | ▼ -56.8% |
| 2019 | 0.83x | CN¥537.94 Million | CN¥491.58 Million | CN¥650.49 Million | ▲ +42.6% |
| 2018 | 0.58x | CN¥333.21 Million | CN¥308.24 Million | CN¥574.67 Million | ▼ -29.7% |
| 2017 | 0.82x | CN¥398.08 Million | CN¥356.17 Million | CN¥482.99 Million | ▲ +29.7% |
| 2016 | 0.64x | CN¥304.84 Million | CN¥239.60 Million | CN¥479.88 Million | ▲ +8.4% |
| 2015 | 0.59x | CN¥306.78 Million | CN¥182.85 Million | CN¥523.31 Million | ▲ +30.6% |
| 2014 | 0.45x | CN¥218.54 Million | CN¥111.67 Million | CN¥486.89 Million | ▼ -3.1% |
| 2013 | 0.46x | CN¥213.62 Million | CN¥129.94 Million | CN¥461.22 Million | ▼ -6.1% |
| 2012 | 0.49x | CN¥202.01 Million | CN¥169.25 Million | CN¥409.56 Million | ▲ +38.7% |
| 2011 | 0.36x | CN¥120.06 Million | CN¥75.37 Million | CN¥337.70 Million | ▲ +416.9% |
| 2010 | 0.07x | CN¥22.13 Million | CN¥-11.42 Million | CN¥321.68 Million | ▼ -89.5% |
| 2009 | 0.65x | CN¥251.05 Million | CN¥216.11 Million | CN¥384.11 Million | ▲ +40.7% |
| 2008 | 0.46x | CN¥135.43 Million | CN¥102.59 Million | CN¥291.46 Million | ▲ +256.0% |
| 2007 | 0.13x | CN¥31.13 Million | CN¥6.49 Million | CN¥238.53 Million | ▼ -66.1% |
| 2006 | 0.39x | CN¥96.59 Million | CN¥75.27 Million | CN¥250.53 Million | ▼ -28.3% |
| 2005 | 0.54x | CN¥94.38 Million | CN¥58.43 Million | CN¥175.45 Million | ▼ -15.4% |
| 2004 | 0.64x | CN¥83.13 Million | CN¥54.19 Million | CN¥130.74 Million | ▲ +5.9% |
| 2003 | 0.60x | CN¥82.05 Million | CN¥67.52 Million | CN¥136.61 Million | — |